Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Degarelix for treating advanced hormone‐sensitive prostate cancer

Esta versión no es la más reciente

ver la versión actual 05 agosto 2021

Información

DOI:
https://doi.org/10.1002/14651858.CD012548Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 08 febrero 2017see what's new
Tipo:
  1. Intervention
Etapa:
  1. Protocol
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Urología

Copyright:
  1. Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Joachim J Jakob

    Correspondencia a: Department of Urology, University Hospital Ulm, Ulm, Germany

    [email protected]

  • Stefanie Schmidt

    UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Germany

  • Frank Kunath

    UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Germany

    Department of Urology, University Hospital Erlangen, Erlangen, Germany

  • Joerg J Meerpohl

    Cochrane France, Centre de Recherche Épidémiologie et Statistique Sorbonne Paris Cité (CRESS), Inserm UMR1153, Paris Descartes University, Paris, France

  • Anette Blümle

    Cochrane Germany, Medical Center – Univ. of Freiburg, Faculty of Medicine, Univ. of Freiburg, Freiburg, Germany

  • Christine Schmucker

    Cochrane Germany, Medical Center – Univ. of Freiburg, Faculty of Medicine, Univ. of Freiburg, Freiburg, Germany

  • Benjamin Mayer

    Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany

  • Friedemann Zengerling

    Department of Urology, University Hospital Ulm, Ulm, Germany

    UroEvidence@Deutsche Gesellschaft für Urologie, Berlin, Germany

Contributions of authors

Joachim J Jakob (JJJ): title/abstract screening, acquiring trial reports, full‐text screening, data extraction, data analysis, data interpretation, review drafting, future review updates.

Stefanie Schmidt (SS): critical review of protocol and manuscript, risk of bias assessment, methodological advice.

Frank Kunath (FK): protocol drafting, search strategy development, data interpretation, review drafting, critical review of manuscript.

Joerg J Meerpohl (JJM): protocol and review drafting, data analysis, data interpretation, critical review of manuscript, methodological advice.

Anette Blümle (AB): data extraction, data interpretation, review drafting.

Christine Schmucker (CS): third reviewer for the selection of studies/evaluation of adverse events, risk of bias assessment, review drafting.

Benjamin Mayer (BM): data analysis, data interpretation, critical review of manuscript, methodological advice.

Friedemann Zengerling (FZ): title/abstract screening, acquiring trial reports, full‐text screening, data extraction, data analysis, review drafting.

Declarations of interest

JJJ, SS, FK, JJM, AB, CS, BM, FZ: none known

Acknowledgements

We would like to thank Philipp Dahm for his support in drafting this protocol. Furthermore we would like to acknowledge the help of Amr H Wahba in preparing this protocol.

Version history

Published

Title

Stage

Authors

Version

2021 Aug 05

Degarelix for treating advanced hormone‐sensitive prostate cancer

Review

Friedemann Zengerling, Joachim J Jakob, Stefanie Schmidt, Joerg J Meerpohl, Anette Blümle, Christine Schmucker, Benjamin Mayer, Frank Kunath

https://doi.org/10.1002/14651858.CD012548.pub2

2017 Feb 08

Degarelix for treating advanced hormone‐sensitive prostate cancer

Protocol

Joachim J Jakob, Stefanie Schmidt, Frank Kunath, Joerg J Meerpohl, Anette Blümle, Christine Schmucker, Benjamin Mayer, Friedemann Zengerling

https://doi.org/10.1002/14651858.CD012548

Notes

Parts of the Methods section and Appendix 1 of this protocol are based on a standard template developed by the Cochrane Metabolic and Endocrine Disorders Group that has been modified and adapted for use by the Cochrane Urology Group.

Keywords

MeSH

Medical Subject Headings (MeSH) Keywords

Medical Subject Headings Check Words

Humans; Male;

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.